RIDECLAS: Delphi Classification of RICA Pathway Recommendations
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversidad de Zaragoza
About this trial
RIDECLAS is an observational, prospective, non-interventional consensus study using a modified Delphi methodology. The study aims to obtain expert consensus on the classification and final formulation of recommendations for the RICA Pathway, an enhanced recovery pathway for adult surgery. Participants will be healthcare professionals with experience in enhanced recovery, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines. Experts will complete sequential online questionnaires. Individual responses will remain confidential, and aggregated anonymized feedback will be provided between Delphi rounds. The study does not involve patients, clinical interventions, biological samples, drugs, or medical devices.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Healthcare professional or researcher with relevant clinical or scientific experience in enhanced recovery pathways, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines.
Disqualifiers
Failure to meet the predefined professional experience criteria. Failure to provide informed consent. Failure to complete the first Delphi round. Duplicate or incomplete responses that cannot be validated for analysis.
Trial population
The study population will consist of healthcare professionals and scientific society members with experience in enhanced recovery pathways, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines. Participants will be invited from the Grupo Español de Rehabilitación Multimodal (GERM) and related professional networks.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Modified Delphi questionnaire
Other interventionSequential online questionnaires used to rate and classify proposed RICA Pathway recommendations. This is not a clinical intervention and does not involve patient care, drugs, devices, or invasive procedures.
Treatment groups
384 Participants
are divided into 1 treatment groupGroup A: Expert Panel1 intervention
Trial outcomes
Primary outcomes
1
Expert consensus on RICA Pathway recommendations
Consensus will be assessed for each recommendation using predefined Delphi criteria. Acceptance consensus will be defined as at least 75% of ratings in the 7-9 range and no more than 15% in the 1-3 range. Rejection consensus will be defined as at least 75% of ratings in the 1-3 range and no more than 15% in the 7-9 range.
Time frame
Through study completion, up to 7 monthsSecondary outcomes
1
Degree of agreement for each recommendation
Distribution of ratings, median score, interquartile range, and percentage of ratings in predefined agreement/disagreement ranges.
Time frame
After each Delphi round, up to 7 months.2
Stability of ratings between Delphi rounds
Descriptive assessment of changes in item-level ratings and consensus status between rounds.
Time frame
Between round 1 and round 2, and round 3 if performed, up to 7 months.3
Response rate and attrition between rounds
Number and percentage of invited experts who complete each round, and percentage lost between rounds.
Time frame
After each Delphi round, up to 7 months.4
Qualitative analysis of expert comments
Thematic review of free-text comments to support item reformulation and interpretation of items without consensus.
Time frame
After each Delphi round, up to 7 months.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Universidad de Zaragoza
Lead sponsor
Universidad Miguel Hernandez de Elche
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: